(P-2159) Potential Application of a Clinical-Grade Next Generation Sequencing Assay for Detection of Bacterial Vaginosis Associated Organisms in Urine

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Mara Couto-Rodriguez, MS (she/her/hers)

Director of R&D
Biotia Inc.
Brooklyn, New York, United States

SR

Sol Rey, BS

Biotia Inc.
Brooklyn, New York, United States
Heather L. Wells, MPH, PhD Candidate

Consultant
Biotia
New York, New York, United States
EM

Eduardo J. Morfa Romero, MD

SUNY Downstate Health Sciences University
Brooklyn, New York, United States
AP

Anna Plourde, MD, MPH

SUNY Downstate Medical Center
Brooklyn, New York, United States
MA

Michael Augenbraun, MD

Division Chief
SUNY Downstate Medical University
Brooklyn, NY, United States
TR

Tiara Rivera, B.S.

NGS Technician
Biotia
Brooklyn, New York, United States
XJ

Xavier O. Jirau Serrano, MS

NGS Research Scientist
Biotia Inc.
New York, New York, United States
JP

John C. Papciak, BS

Biotia Inc.
New York, New York, United States
CO

Caitlin Otto, PhD, D(ABMM)

Biotia Inc.
New York, New York, United States
DD

David C. Danko, Ph.D.

CTO
Biotia
Manhattan, New York, United States
CM

Christopher E. Mason, PhD

Co-Founder
Biotia Inc.
New York, New York, United States
NO

Niamh B. O'Hara, PhD

Chief Executive Officer and Co-Founder
Biotia Inc.
New York, New York, United States
Dorottya Nagy-Szakal, MD PhD (she/her/hers)

Chief Medical Officer
Biotia Inc.
New York, New York, United States